A Phase 3B, Double-Blind, Randomized, Placebo-Controlled Study of Rotigotine and Its Effect on All-Day Functioning and Quality of Life in Subjects with Moderate to Severe Idiopathic Restless Legs Syndrome

Kelly L. Sullivan

A Phase 3B, Double-Blind, Randomized, Placebo-Controlled Study of Rotigotine and Its Effect on All-Day Functioning and Quality of Life in Subjects with Moderate to Severe Idiopathic Restless Legs Syndrome

Kelly L. Sullivan

Biostatistics, Epidemiology & Environmental Health Sciences

Research output: Other contribution › Other

Original language	American English
State	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Disciplines

Epidemiology
Public Health

Cite this

@misc{646f6a0c3beb49cb8d6f38ca010fda25,

title = "A Phase 3B, Double-Blind, Randomized, Placebo-Controlled Study of Rotigotine and Its Effect on All-Day Functioning and Quality of Life in Subjects with Moderate to Severe Idiopathic Restless Legs Syndrome",

author = "Sullivan, \{Kelly L.\}",

note = "Kelly L. Sullivan (Coordinator), {"}A Phase 3B, Double-Blind, Randomized, Placebo-Controlled Study of Rotigotine and Its Effect on All-Day Functioning and Quality of Life in Subjects with Moderate to Severe Idiopathic Restless Legs Syndrome,{"} UCB Pharma. (2012-2013).",

year = "2012",

language = "American English",

type = "Other",

}

TY - GEN

T1 - A Phase 3B, Double-Blind, Randomized, Placebo-Controlled Study of Rotigotine and Its Effect on All-Day Functioning and Quality of Life in Subjects with Moderate to Severe Idiopathic Restless Legs Syndrome

AU - Sullivan, Kelly L.

N1 - Kelly L. Sullivan (Coordinator), "A Phase 3B, Double-Blind, Randomized, Placebo-Controlled Study of Rotigotine and Its Effect on All-Day Functioning and Quality of Life in Subjects with Moderate to Severe Idiopathic Restless Legs Syndrome," UCB Pharma. (2012-2013).

PY - 2012

Y1 - 2012

UR - https://clinicaltrials.gov/show/NCT01569464

M3 - Other

ER -

A Phase 3B, Double-Blind, Randomized, Placebo-Controlled Study of Rotigotine and Its Effect on All-Day Functioning and Quality of Life in Subjects with Moderate to Severe Idiopathic Restless Legs Syndrome

UN SDGs

Disciplines

Other files and links

Cite this